|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,212.00 JPY | -1.29% |
|
-0.40% | -12.51% |
| 07-21 | Japan Shares Rebound as Tech Earnings Season Commences | MT |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| Market Cap | 12,024B 73.72B 64.59B 59.96B 55.1B 104B 7,113B 105B 714B 280B 3,481B 277B 271B | P/E 2026 * |
23.6x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 11,102B 68.06B 59.64B 55.37B 50.88B 95.87B 6,568B 97.28B 660B 258B 3,214B 256B 250B | EV / Sales 2026 * |
8x | EV / Sales 2027 * | 7.07x |
| Free-Float |
38.12% | Yield 2026 * |
1.87% | Yield 2027 * | 2.15% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -1.29% | ||
| 1 week | -0.40% | ||
| Current month | -4.27% | ||
| 1 month | -2.99% | ||
| 3 months | -19.20% | ||
| 6 months | -17.61% | ||
| Current year | -12.51% |
| 1 week | 7,163 |  | 7,444 |
| 1 month | 7,105 | | 7,939 |
| Current year | 7,105 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,939 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 01/03/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
| Director/Board Member | 51 | 01/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | -0.40% | +1.33% | +77.24% | 73.72B | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,037B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 615B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 448B | |
| +2.62% | +3.14% | +30.88% | +25.05% | 326B | |
| -0.65% | +1.22% | +33.98% | +37.40% | 293B | |
| -0.89% | -0.11% | +18.18% | +17.01% | 264B | |
| -1.76% | -6.80% | -29.32% | -43.10% | 216B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | -0.18% | +1.26% | +23.05% | +50.93% | 363.12B | |
| Weighted average by Cap. | -0.19% | +1.50% | +34.44% | +72.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.51B 7.45B 6.92B 6.36B 11.98B 821B 12.16B 82.43B 32.26B 402B 31.93B 31.24B | 1,535B 9.41B 8.25B 7.66B 7.04B 13.26B 908B 13.45B 91.21B 35.7B 444B 35.33B 34.57B |
| Net income | 509B 3.12B 2.73B 2.54B 2.33B 4.39B 301B 4.46B 30.24B 11.83B 147B 11.71B 11.46B | 593B 3.63B 3.18B 2.96B 2.72B 5.12B 351B 5.19B 35.22B 13.78B 172B 13.64B 13.35B |
| Net Debt | -922B -5.65B -4.95B -4.6B -4.23B -7.96B -545B -8.08B -54.77B -21.44B -267B -21.22B -20.76B | -1,164B -7.14B -6.25B -5.81B -5.33B -10.05B -689B -10.2B -69.16B -27.07B -337B -26.79B -26.21B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | ¥7,212.00 | -1.29% | 2,609,800 |
| 22/07/26 | ¥7,306.00 | -1.23% | 2,064,700 |
| 21/07/26 | ¥7,397.00 | +0.98% | 3,264,000 |
| 17/07/26 | ¥7,325.00 | +1.16% | 2,964,200 |
| 16/07/26 | ¥7,241.00 | +1.59% | 2,301,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
